The effect of tetracycline on levels of oral contraceptives

Ana A. Murphy, Howard A Zacur, Patricia Charache, Ronald T. Burkman

Research output: Contribution to journalArticle

Abstract

Despite the widespread use of tetracycline for treatment of dermatologic disorders and sexually transmitted diseases, the pharmacodynamics of oral contraceptive use in the presence of tetracycline has not been studied. Seven normal women ingested an oral contraceptive containing ethinyl estradiol 35 μg and norethindrone 1 mg in the follicular phase of the menstrual cycle. On day 0 baseline ethinyl estradiol and norethindrone levels were obtained at 0, 1 2, 3 4, 1, 2, 4, 12, and 24 hours after oral contraceptive administration. On day 1 tetracycline 500 mg was given orally every 6 hours while the oral contraceptive was continued. Tetracycline, ethinyl estradiol, and norethindrone levels were determined at the same time intervals as on day 0. Oral contraceptive and tetracycline were continued for up to 10 days, and additional concentrations of ethinyl estradiol, norethindrone, and tetracycline were determined between days 5 and 10. Four additional normal women ingested tetracycline for 5 to 10 days. Tetracycline levels were determined at the time intervals noted above on day 1 and days 5 to 10. No significant decrease in plasma ethinyl estradiol or norethindrone concentration was seen with either short-term (24 hours) or long-term (5 to 10 days) ingestion of tetracycline. Similarly, levels of tetracycline do not significantly decrease with ingestion of a low-dose oral contraceptive.

Original languageEnglish (US)
Pages (from-to)28-33
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Volume164
Issue number1 PART 1
DOIs
StatePublished - 1991

Fingerprint

Oral Contraceptives
Tetracycline
Norethindrone
Ethinyl Estradiol
Eating
Follicular Phase
Sexually Transmitted Diseases
Oral Administration

Keywords

  • ethinyl estradiol
  • norethindrone
  • Oral contraceptives
  • tetracycline

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

The effect of tetracycline on levels of oral contraceptives. / Murphy, Ana A.; Zacur, Howard A; Charache, Patricia; Burkman, Ronald T.

In: American Journal of Obstetrics and Gynecology, Vol. 164, No. 1 PART 1, 1991, p. 28-33.

Research output: Contribution to journalArticle

Murphy, Ana A. ; Zacur, Howard A ; Charache, Patricia ; Burkman, Ronald T. / The effect of tetracycline on levels of oral contraceptives. In: American Journal of Obstetrics and Gynecology. 1991 ; Vol. 164, No. 1 PART 1. pp. 28-33.
@article{92b5b0ccab124d229dc7925b88e8692a,
title = "The effect of tetracycline on levels of oral contraceptives",
abstract = "Despite the widespread use of tetracycline for treatment of dermatologic disorders and sexually transmitted diseases, the pharmacodynamics of oral contraceptive use in the presence of tetracycline has not been studied. Seven normal women ingested an oral contraceptive containing ethinyl estradiol 35 μg and norethindrone 1 mg in the follicular phase of the menstrual cycle. On day 0 baseline ethinyl estradiol and norethindrone levels were obtained at 0, 1 2, 3 4, 1, 2, 4, 12, and 24 hours after oral contraceptive administration. On day 1 tetracycline 500 mg was given orally every 6 hours while the oral contraceptive was continued. Tetracycline, ethinyl estradiol, and norethindrone levels were determined at the same time intervals as on day 0. Oral contraceptive and tetracycline were continued for up to 10 days, and additional concentrations of ethinyl estradiol, norethindrone, and tetracycline were determined between days 5 and 10. Four additional normal women ingested tetracycline for 5 to 10 days. Tetracycline levels were determined at the time intervals noted above on day 1 and days 5 to 10. No significant decrease in plasma ethinyl estradiol or norethindrone concentration was seen with either short-term (24 hours) or long-term (5 to 10 days) ingestion of tetracycline. Similarly, levels of tetracycline do not significantly decrease with ingestion of a low-dose oral contraceptive.",
keywords = "ethinyl estradiol, norethindrone, Oral contraceptives, tetracycline",
author = "Murphy, {Ana A.} and Zacur, {Howard A} and Patricia Charache and Burkman, {Ronald T.}",
year = "1991",
doi = "10.1016/0002-9378(91)90617-Z",
language = "English (US)",
volume = "164",
pages = "28--33",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1 PART 1",

}

TY - JOUR

T1 - The effect of tetracycline on levels of oral contraceptives

AU - Murphy, Ana A.

AU - Zacur, Howard A

AU - Charache, Patricia

AU - Burkman, Ronald T.

PY - 1991

Y1 - 1991

N2 - Despite the widespread use of tetracycline for treatment of dermatologic disorders and sexually transmitted diseases, the pharmacodynamics of oral contraceptive use in the presence of tetracycline has not been studied. Seven normal women ingested an oral contraceptive containing ethinyl estradiol 35 μg and norethindrone 1 mg in the follicular phase of the menstrual cycle. On day 0 baseline ethinyl estradiol and norethindrone levels were obtained at 0, 1 2, 3 4, 1, 2, 4, 12, and 24 hours after oral contraceptive administration. On day 1 tetracycline 500 mg was given orally every 6 hours while the oral contraceptive was continued. Tetracycline, ethinyl estradiol, and norethindrone levels were determined at the same time intervals as on day 0. Oral contraceptive and tetracycline were continued for up to 10 days, and additional concentrations of ethinyl estradiol, norethindrone, and tetracycline were determined between days 5 and 10. Four additional normal women ingested tetracycline for 5 to 10 days. Tetracycline levels were determined at the time intervals noted above on day 1 and days 5 to 10. No significant decrease in plasma ethinyl estradiol or norethindrone concentration was seen with either short-term (24 hours) or long-term (5 to 10 days) ingestion of tetracycline. Similarly, levels of tetracycline do not significantly decrease with ingestion of a low-dose oral contraceptive.

AB - Despite the widespread use of tetracycline for treatment of dermatologic disorders and sexually transmitted diseases, the pharmacodynamics of oral contraceptive use in the presence of tetracycline has not been studied. Seven normal women ingested an oral contraceptive containing ethinyl estradiol 35 μg and norethindrone 1 mg in the follicular phase of the menstrual cycle. On day 0 baseline ethinyl estradiol and norethindrone levels were obtained at 0, 1 2, 3 4, 1, 2, 4, 12, and 24 hours after oral contraceptive administration. On day 1 tetracycline 500 mg was given orally every 6 hours while the oral contraceptive was continued. Tetracycline, ethinyl estradiol, and norethindrone levels were determined at the same time intervals as on day 0. Oral contraceptive and tetracycline were continued for up to 10 days, and additional concentrations of ethinyl estradiol, norethindrone, and tetracycline were determined between days 5 and 10. Four additional normal women ingested tetracycline for 5 to 10 days. Tetracycline levels were determined at the time intervals noted above on day 1 and days 5 to 10. No significant decrease in plasma ethinyl estradiol or norethindrone concentration was seen with either short-term (24 hours) or long-term (5 to 10 days) ingestion of tetracycline. Similarly, levels of tetracycline do not significantly decrease with ingestion of a low-dose oral contraceptive.

KW - ethinyl estradiol

KW - norethindrone

KW - Oral contraceptives

KW - tetracycline

UR - http://www.scopus.com/inward/record.url?scp=0025961979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025961979&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(91)90617-Z

DO - 10.1016/0002-9378(91)90617-Z

M3 - Article

C2 - 1986620

AN - SCOPUS:0025961979

VL - 164

SP - 28

EP - 33

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1 PART 1

ER -